top of page

Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.


Drugs: What are they good for? - 5-MeO-DMT
5-methoxy-N,N-dimethyltryptamine, or ‘toad venom’ as it’s better known, is a tryptamine psychedelic that occurs naturally in multiple specie
Sally Turner
Jun 12, 20237 min read


Taking matters into my own hands: Self-taught drug education
Written by AJ Martin – President of the Imperial College Students for Sensible Drug Policy Engaging in the drug science and policy space...
AJ Martin
Apr 3, 20233 min read


Preliminary findings from T21 Australia
An observational study of patients prescribed medicinal Cannabis for chronic pain, anxiety, posttraumatic stress disorder and multiple...
Kylie O’Brien, Justin Beilby and more
Mar 23, 20232 min read


Combating the stigma: a T21 success story
By Louise McConnell Although medical cannabis has been legal in the UK for more than four years, there still exists a great deal of...
Louise McConnell
Mar 20, 20232 min read


Response from Drug Science to the Australian Government consultation on potential reforms to the regulation of nicotine vaping products
Border controls No legislative changes ought to be made to Australia’s current border controls for nicotine products. The black market...
Drug Science
Jan 19, 20239 min read


Neuroplasticity in Mental Health Recovery: Prompting the Brain to Cure Itself
Written by Tiago Vasconcelos Psychiatric disorders can be considered to disturb the brain’s equilibria, emerging when different factors...
Tiago Vasconcelos
Jan 5, 20238 min read


Busting the Myths Surrounding Psychedelics
Prof. Jo Neill The generalised public perception of psychedelic drugs is rooted in their legal categorisation as a Class A, Schedule 1...
Drug Science
Dec 28, 20224 min read


50 Years of Failed Drug Policy – Event Review
By Karolina Wilgus Since 1971, The Misuse of Drugs Act (MDA) has yielded suffering, halted life-saving research, and put overwhelming...
Karolina Wilgus
Dec 22, 20223 min read


Would you let your teenager try psychedelics?
By Alice Lineham *Note that throughout this article the term ‘teenager’ is used to refer to individuals between the ages of 13-18 Since...
Alice Lineham
Nov 15, 202210 min read


The United Kingdom's Psychoactive Substances Act 2016. Where are we now?
Authors Christopher Humphries Published November 14th, 2022 This narrative review describes the background to the introduction of the UK...
Christopher Humphries
Nov 14, 20221 min read


Indigenous washing: the exploitation of indigenous people by the pharmaceutical industry
Article written by Jemima Lowe and Kirran Ahmad Indigenous populations¹ are active stewards of our planet and resources, safeguarding 80%...
Jemima Lowe and Kirran Ahmad
Nov 9, 20227 min read


An Exploration of Psychedelics and Creativity
Event review written by Nikol Naydenova At the edge of central London, over 300 people gathered in an Art Deco cinema eager to listen and...
Nikol Naydenova
Oct 26, 20223 min read


The Drug Enforcement Agency listens to psychedelic experts
By Professor David Nutt and James Bunn The Drug Enforcement Agency (DEA) recently withdrew a proposal to ban five psychedelic substances:...
Professor David Nutt and James Bunn
Aug 5, 20224 min read


Over One Hundred Years of MDMA Research
Written by Libby Furminger History 3,4-Methylenedioxymethamphetamine (MDMA), also known as Mandy, Molly, Ecstasy or ‘E’, is a class A...
Libby Furminger
Jun 29, 202210 min read


Characteristics of People Seeking Prescribed Cannabinoids for the Treatment of Chronic Pain: Evidence From Project Twenty 21
Authors Anne Katrin Schlag, Michael Lynskey, Alan Fayaz, Alkyoni Athanasiou-Fragkouli, Brigitta Brandner, Barbara Haja, Elizabeth Iveson...
Dr Anne Schlag, Professor David Nutt and more
Jun 13, 20223 min read


The Post COVID cathinone hydra
Written by Professor Fiona Measham and Dr Michael Pascoe A study published in the journal of Drug Science Policy and Law describes...
Professor Fiona Measham and Dr Michael Pascoe
Jun 8, 20225 min read


Ketamine for Alcohol Use Disorder
Written by Tiago Vasconcelos. A review of the recent paper – ‘Adjunctive Ketamine With Relapse Prevention–Based Psychological Therapy in...
Tiago Vasconcelos
May 24, 20225 min read


Psilocybin Therapy for Treatment-Resistant Depression
Topline Results from COMPASS Pathways Phase IIb Trial By Olivia Gorzynska In November 2021, COMPASS Pathways, a mental health care...
Olivia Gorzynska
Apr 29, 20224 min read


Tripping over red tape: psychedelics for mental health
The last decade has seen a new focus on psychedelics as powerful medicines for treating severe mental health issues, including the use of...
Drug Science
Mar 7, 20225 min read


2022 Drug Trend Report: Time, Music, Clubbing, Age, and Diet
By Adam Winstock, Rasmus Munksgaard, Emma Davies, Jason Ferris, Ahnjili ZhuParris, Monica Barratt Full report can be found on The Global...
Adam Winstock, Rasmus Munksgaard and more
Mar 1, 20223 min read


What is DMT therapy?
By Dr Carol Routledge, Chief Medical & Scientific Officer at Small Pharma DMT-assisted therapy is a novel psychedelic therapy which aims...
Dr Carol Routledge
Feb 11, 20226 min read
bottom of page
